John D Dobak's most recent trade in DermTech Inc was a trade of 56,407 Common Stock done . Disclosure was reported to the exchange on March 9, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 56,407 | 700,252 (5%) | 0% | 0 | Common Stock | |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.26 per share. | 09 Mar 2023 | 1,559 | 698,693 (5%) | 0% | 3.3 | 5,082 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 07 Mar 2023 | 23,246 | 643,845 (5%) | 0% | 4.1 | 94,379 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 07 Mar 2023 | 709 | 667,091 (5%) | 0% | 4.1 | 2,879 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | 27 May 2022 | 9,219 | 0 | - | - | Warrant to Purchase Common Stock | ||
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | 27 May 2022 | 9,219 | 665,295 (5%) | 0% | 1.1 | 9,957 | Common Stock | |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 11 Mar 2022 | 1,326 | 446,549 (3%) | 0% | 14.5 | 19,293 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 07 Mar 2022 | 2,561 | 448,661 (3%) | 0% | 13.0 | 33,370 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.64 per share. | 07 Mar 2022 | 786 | 447,875 (3%) | 0% | 12.6 | 9,935 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.71 per share. | 13 Dec 2021 | 1,964 | 450,562 (3%) | 0% | 16.7 | 32,818 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.19 per share. | 13 Sep 2021 | 1,899 | 453,645 (3%) | 0% | 36.2 | 68,725 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.08 per share. | 11 Jun 2021 | 7,651 | 468,847 (3%) | 0% | 41.1 | 314,322 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 43.43 per share. | 08 Jun 2021 | 1,118 | 476,498 (3%) | 0% | 43.4 | 48,555 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Jun 2021 | 9,530 | 477,616 (3%) | 0% | 40 | 381,200 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.22 per share. | 01 Jun 2021 | 2,970 | 487,146 (3%) | 0% | 40.2 | 119,443 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.51 per share. | 03 May 2021 | 16,021 | 499,095 (4%) | 0% | 40.5 | 649,060 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.53 per share. | 03 May 2021 | 6,808 | 492,287 (3%) | 0% | 41.5 | 282,708 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 42.45 per share. | 03 May 2021 | 2,171 | 490,116 (3%) | 0% | 42.5 | 92,162 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.35 per share. | 27 Apr 2021 | 25,000 | 515,116 (4%) | 0% | 51.4 | 1,283,750 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.94 per share. | 12 Apr 2021 | 14,343 | 550,773 (4%) | 0% | 45.9 | 658,849 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.79 per share. | 12 Apr 2021 | 9,736 | 541,037 (4%) | 0% | 46.8 | 455,534 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 47.90 per share. | 12 Apr 2021 | 921 | 540,116 (4%) | 0% | 47.9 | 44,118 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 43,455 | 43,455 | - | - | Stock Option (right to buy) | |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 29,195 | 565,116 (4%) | 0% | 0 | Common Stock | |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.35 per share. | 18 Mar 2021 | 7,150 | 535,921 (4%) | 0% | 53.4 | 381,453 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.04 per share. | 08 Mar 2021 | 780 | 543,071 (4%) | 0% | 50.0 | 39,031 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.86 per share. | 08 Dec 2020 | 786 | 541,683 (4%) | 0% | 11.9 | 9,322 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.58 per share. | 10 Sep 2020 | 1,560 | 543,379 (4%) | 0% | 10.6 | 16,497 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.25 per share. | 10 Sep 2020 | 910 | 542,469 (4%) | 0% | 11.3 | 10,238 | Common Stock |